Following the adoption of restrictive guidelines for gadolinium-based contrast agent administration, no new nephrogenic systemic fibrosis cases have been identified in contrast-enhanced magnetic resonance examinations, even in patients with a low estimated glomerular filtration rate, according to a study published in Radiology. Yingbing Wang, M.D., from Massachusetts General Hospital in Boston, and colleagues compared the incidence of NSF before and after the adoption of restrictive GBCA administration guidelines in 2007. The guidelines limited the maximum GBCA dose to 20 mL in patients with low eGFR (60 mL/min/m

Like

Dislike

Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.

"Exciting news! Elets technomedia is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest insights!" Click here!